Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ: OLMA · Real-Time Price · USD
6.25
-0.08 (-1.19%)
Dec 26, 2024, 11:44 AM EST - Market open
Olema Pharmaceuticals Market Cap
Olema Pharmaceuticals has a market cap or net worth of $357.57 million as of December 26, 2024. Its market cap has decreased by -42.78% in one year.
Market Cap
357.57M
Enterprise Value
148.80M
1-Year Change
-42.78%
Ranking
Category
Stock Price
$6.25
Market Cap Chart
Since the IPO on November 19, 2020, Olema Pharmaceuticals's market cap has decreased from $1.79B to $357.57M, a decrease of -80.07%. That is a compound annual growth rate of -32.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2024 | 361.87M | -52.78% |
| Dec 29, 2023 | 766.34M | 679.84% |
| Dec 30, 2022 | 98.27M | -73.58% |
| Dec 31, 2021 | 372.01M | -79.78% |
| Dec 31, 2020 | 1.84B | 2.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| IGM Biosciences | 377.00M |
| Taysha Gene Therapies | 373.00M |
| REGENXBIO | 371.59M |
| Contineum Therapeutics | 369.40M |
| Y-mAbs Therapeutics | 365.25M |
| Delcath Systems | 359.39M |
| AngioDynamics | 353.52M |
| Design Therapeutics | 352.75M |